| scholarly article | Q13442814 |
| P2093 | author name string | John C McDermott | |
| Jahan Salma | |||
| P2860 | cites work | A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 |
| hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors | Q24322986 | ||
| Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1 | Q24548255 | ||
| MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex | Q24563497 | ||
| MEF2: a calcium-dependent regulator of cell division, differentiation and death | Q28215798 | ||
| MEF2: a central regulator of diverse developmental programs | Q28254625 | ||
| MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells | Q28289460 | ||
| Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins | Q28294155 | ||
| Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 | ||
| MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function | Q28507026 | ||
| Increased cerebrospinal fluid cAMP levels in Alzheimer's disease. | Q53337897 | ||
| 6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation. | Q53451849 | ||
| Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages | Q71041807 | ||
| Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation | Q71978735 | ||
| Myocyte-specific enhancer binding factor 2C expression in human brain development | Q72119328 | ||
| TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes | Q72467748 | ||
| RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival | Q74796123 | ||
| Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression | Q77853072 | ||
| Upregulation of Krüppel-like factor 6 in the mouse hippocampus after pilocarpine-induced status epilepticus | Q83505543 | ||
| α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease | Q84979636 | ||
| The expression of MEF2 genes is implicated in CNS neuronal differentiation | Q28511872 | ||
| PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis | Q28566410 | ||
| Developmental homeostasis of mouse retinocollicular synapses | Q28587961 | ||
| The self-tuning neuron: synaptic scaling of excitatory synapses | Q29616059 | ||
| Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. | Q30841374 | ||
| Tuba1a gene expression is regulated by KLF6/7 and is necessary for CNS development and regeneration in zebrafish | Q33721932 | ||
| MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation | Q33796329 | ||
| Molecular mechanisms of neurodegeneration in Alzheimer's disease | Q33871297 | ||
| Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. | Q34087738 | ||
| Cell signaling and the regulation of muscle-specific gene expression by myocyte enhancer-binding factor 2. | Q34115071 | ||
| Temporal regulation of the expression locus of homeostatic plasticity. | Q34535800 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro | Q35184527 | ||
| Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. | Q35503840 | ||
| Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival | Q35764277 | ||
| Role of protein conformational dynamics and DNA integrity in relevance to neuronal cell death in neurodegeneration | Q36611776 | ||
| Regulating gene transcription in response to cyclic AMP elevation | Q36997413 | ||
| Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection | Q37070840 | ||
| Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells | Q37439080 | ||
| Synapse elimination in the central nervous system | Q37501163 | ||
| Regulation of synaptic connectivity by glia | Q37808619 | ||
| Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. | Q39861257 | ||
| Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma | Q40130158 | ||
| Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. | Q40372504 | ||
| Neural apoptosis | Q40925540 | ||
| Protein kinase A-regulated assembly of a MEF2⋅HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells | Q42169993 | ||
| Immunohistochemical localization of Krüppel-like factor 6 in the mouse forebrain | Q42453508 | ||
| Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. | Q44259986 | ||
| A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium | Q44465691 | ||
| Insulin-like growth factor-I suppresses degradation of the pro-survival transcription factor myocyte enhancer factor 2D (MEF2D) during neuronal apoptosis | Q44718177 | ||
| Adult rat hippocampal slices as in vitro models for neurodegeneration: Studies on cell viability and apoptotic processes | Q45084160 | ||
| Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival | Q45285809 | ||
| Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis | Q46652436 | ||
| Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. | Q46890595 | ||
| Amyloid beta-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation | Q46898699 | ||
| The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. | Q48097831 | ||
| Genomic organization and functional analysis of the gene encoding the Krüppel-like transcription factor KLF6. | Q48127585 | ||
| Klf6 is a zinc finger protein expressed in a cell-specific manner during kidney development | Q48373920 | ||
| Differential effects of Ca2+ and cAMP on transcription mediated by MEF2D and cAMP-response element-binding protein in hippocampal neurons | Q48462051 | ||
| Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain | Q48925833 | ||
| Expression of the D-MEF2 transcription in the Drosophila brain suggests a role in neuronal cell differentiation. | Q52201972 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2790-2803 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons | |
| P478 | volume | 32 |
| Q38820712 | A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling |
| Q34345506 | Constructing endophenotypes of complex diseases using non-negative matrix factorization and adjusted rand index |
| Q53059942 | GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury. |
| Q38956956 | Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling |
| Q42777914 | Global Transcriptome Analysis of Primary Cerebrocortical Cells: Identification of Genes Regulated by Triiodothyronine in Specific Cell Types. |
| Q33860807 | Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers |
| Q42610072 | Heart disease: recruitment of MEF2 activity by β-blockers wards off cardiomyocyte death |
| Q46090041 | Identification of Gene Loci That Overlap Between Schizophrenia and Educational Attainment |
| Q36419883 | Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats |
| Q41304555 | Krüppel-like factor 6 (KLF6) promotes cell proliferation in skeletal myoblasts in response to TGFβ/Smad3 signaling |
| Q35064198 | Krüppel-like factor 6 rendered rat Schwann cell more sensitive to apoptosis via upregulating FAS expression |
| Q64120396 | MEF-2 isoforms' (A-D) roles in development and tumorigenesis |
| Q46585492 | MEF2D Mediates the Neuroprotective Effect of Methylene Blue Against Glutamate-Induced Oxidative Damage in HT22 Hippocampal Cells |
| Q35042712 | NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases |
| Q41288601 | Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons |
| Q38836349 | Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin |
| Q39463779 | Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers |
| Q38080479 | The MEF2 family and the brain: from molecules to memory |
| Q38832180 | miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression |
Search more.